PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Progenics Pharmaceuticals Inc's quarterly cash and cash equivalents increased from Dec. 2013 ($65.86 Mil) to Mar. 2014 ($94.04 Mil) but then declined from Mar. 2014 ($94.04 Mil) to Jun. 2014 ($85.35 Mil).
Progenics Pharmaceuticals Inc's annual cash and cash equivalents declined from Dec. 2011 ($70.11 Mil) to Dec. 2012 ($58.84 Mil) but then increased from Dec. 2012 ($58.84 Mil) to Dec. 2013 ($65.86 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Progenics Pharmaceuticals Inc Annual Data
Progenics Pharmaceuticals Inc Quarterly Data